Matthew Hershenhorn

Stock Analyst at Oppenheimer

(2.26)
# 2,647
Out of 5,008 analysts
1
Total ratings
100%
Success rate
8.33%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $118.64
Upside: +55.93%